Related Experiment Videos
A cytochemical assay for osteoclast cathepsin K activity
1Growth Factors Drug Discovery, Johnson and Johnson Pharmaceutical Research and Development, Raritan, NJ 08869, USA. RDoddds@prdus.jnj.com
Cell Biochemistry and Function
|August 12, 2003
Summary
A new cytochemical assay detects cathepsin K activity in osteoclasts within bone sections. This method aids in developing osteoporosis treatments by enabling inhibitor testing on actual bone-resorbing cells.
Area of Science:
- Biochemistry
- Cell Biology
- Bone Biology
Background:
- Cathepsin K, a cysteine protease, is crucial for osteoclast bone resorption.
- Osteoporosis and other osteopenic disorders are linked to excessive bone resorption.
- Targeting cathepsin K offers a therapeutic strategy for antiresorptive treatments.
Purpose of the Study:
- To develop a quantitative cytochemical assay for cathepsin K activity.
- To enable testing of cathepsin K inhibitors directly on osteoclasts within bone.
- To facilitate the analysis of osteoclast activity and lifespan stages.
Main Methods:
- A novel cytochemical assay was developed.
- The assay localizes cathepsin K activity in unfixed, undecalcified cryostat sections.
- Sections were prepared from animal and human bone.
Main Results:
- The assay successfully localized cathepsin K activity within osteoclasts in bone sections.
- This method allows for the direct assessment of enzyme activity in its native cellular environment.
- Osteoclast cathepsin K activity can be visualized and quantified.
Conclusions:
- A new cytochemical assay provides a tool for studying cathepsin K in osteoclasts.
- This assay is valuable for discovering and testing cathepsin K inhibitors for osteoporosis.
- The method aids in understanding osteoclast function and identifying therapeutic targets.